Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOFOSBUVIR\VELPATASVIR vs SOLIFENACIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SOFOSBUVIR\VELPATASVIR vs SOLIFENACIN: Safety Overview

Metric SOFOSBUVIR\VELPATASVIR SOLIFENACIN
Total FAERS Reports 18,042 8,324
Deaths Reported 978 206
Death Rate 5.4% 2.5%
Hospitalizations 2,342 1,201
Average Patient Age 54.5 yrs 68.9 yrs
% Female Patients 42.5% 68.1%
FDA Approval Date N/A Apr 13, 2020
Manufacturer N/A Ajanta Pharma USA Inc.
Route N/A ORAL
Marketing Status N/A Discontinued